A Randomised Clinical Trial Of Internet-based Treatment For Binge Drinking And Depression In Young Australians
Funder
National Health and Medical Research Council
Funding Amount
$941,787.00
Summary
This project focuses on a common clinical problem that causes substantial functional, economic and health impacts; comorbid depression and binge drinking. These conditions are under-treated and peak in young adulthood. This project offers a low cost, wide reach, youth-appropriate treatment, which will have profound implications for service design and health policy. It relates to current Commonwealth initiatives in e-health and e-Psychology.
Innovative Responses To Prevention And Treatment Of Mental Disorders And Substance Use.
Funder
National Health and Medical Research Council
Funding Amount
$772,490.00
Summary
My vision is to build the world’s leading dedicated translational research program for the prevention and treatment of comorbid mental health and substance abuse. While it is widely recognised that there is significant comorbidity in these two areas they have traditionally been approached in isolation, making it virtually impossible to make significant inroads. I seek to increase our understanding, prevent these where possible and improve treatment responses.
Externalising Behaviours In Young People: Predictors, Prevention And Treatment.
Funder
National Health and Medical Research Council
Funding Amount
$314,644.00
Summary
This Fellowship aims to reduce the burden associated with externalising behaviours (including aggression, violence, substance use, attention-deficit/hyperactivity disorder (ADHD), conduct disorder (CD), oppositional defiant disorder (ODD) and Substance Use Disorders (SUDs)) among young people in Australia. This body of work will provide a comprehensive assessment of the predictors, prevention and treatment of externalising behaviours, so as to inform resource allocation and service delivery.
Exploring The Efficacy And Biobehavioural Basis Of Baclofen In The Treatment Of Alcoholic Liver Disease.
Funder
National Health and Medical Research Council
Funding Amount
$661,197.00
Summary
Alcoholic liver disease (ALD) is the main cause of death from alcohol consumption. Early detection of the disease and subsequent abstinence from alcohol can prevent death and disability. Current medications to help control alcohol consumption are not suitable for use in this patient population owing to the risk of liver side-effects. This study investigates the novel use of an existing medication, baclofen, to safely help maintain abstinence from alcohol in patients suffering from ALD.
The N-ICE Trial: A Randomised Controlled Trial Of The Safety And Efficacy Of N-Acetyl Cysteine (NAC) As A Pharmacotherapy For Methamphetamine (“ice”) Dependence
Funder
National Health and Medical Research Council
Funding Amount
$1,551,368.00
Summary
Crystalline methamphetamine (aka ‘ice’) is a significant public health concern in Australia and globally. Currently there are no approved medications to treat methamphetamine dependence. We will trial tN-acetyl-cysteine (NAC) as a medications for methamphetamine dependence.
Alcohol,tobacco, Illicit And Prescribed Drugs: Prospective Cohorts And RCTs
Funder
National Health and Medical Research Council
Funding Amount
$714,745.00
Summary
This research addresses the important areas of infant, childhood, adolescent, adult, and family well-being and the effects of exposure to tobacco, alcohol, and illicit drug use. The impacts of these substances on psychological, cognitive, vocational, and physical well-being remain poorly researched. A related set of research projects is aimed to build the evidence base for effective intervention to prevent or manage psychological and cognitive sequelae from such exposure.